Fig. 1From: Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapyA Schematic representation of the VEGFR protein domain structure; B the overlap of crystal structures of VEGFR3 (pink), VEGFR2 (PDB ID: 3WZE, brown) and VEGFR1 (PDB ID: 3HNG, blue). The structure of VEGFR1 and VEGFR2 was utilized to construct the homology model of human VEGFR3; C mechanisms of tumor angiogenesis regulated by VEGFR signalingBack to article page